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Abstract
Background: In 2009 the United States Preventive Services Task Force updated its breast cancer screening guidelines
to recommend that average-risk women obtain a screening mammogram every two years starting at age 50 instead of
annually starting at age 40. Inconsistencies in data regarding the benefit versus risk of routine screening for women
less than 50-years-of-age led to a second recommendation – that women in their forties engage in a shared decision
making process with their provider to make an individualized choice about screening mammography that was right
for them. In response, a web-based interactive mammography screening decision aid was developed and evaluated.
Methods: The decision aid was developed using an agile, iterative process. It was further honed based on feedback
from clinical and technical subject matter experts. A convenience sample of 51 age- and risk-appropriate women was
recruited to pilot the aid. Pre-post decisional conflict and screening choice was assessed.
Results: Women reported a significant reduction in overall decisional conflict after using the decision aid (Z = -5.3,
p < 0.001). These participants also reported statistically significant reductions in each of the decisional conflict subscales:
feeling uncertain (Z = -4.7, p < 0.001), feeling uninformed (Z = -5.2, p < 0.001), feeling unclear about values (Z = -5.0,
p < 0.001), and feeling unsupported (Z = -4.0, p < 0.001). However, a woman’s intention to obtain a screening
mammogram in the next 1-2 years was not significantly changed (Wilcoxon signed-rank Z = -1.508, p = 0.132).
Conclusion: This mammography screening decision aid brings value to patient care not by impacting what a
woman chooses but by lending clarity to why or how she chooses it.
Keywords: Decision support techniques, Mammography, Screening, Cancer prevention, Patient preferences,
Decision aid
Background
Concern and disagreement was voiced when the United
States Preventive Services Task Force (USPSTF) updated
its breast cancer screening guidelines in November 2009
[1–6]. The guidelines transitioned from recommending
that average-risk women obtain a screening mammo-
gram yearly starting at age 40 to now undergoing
screening every two years starting at age 50 [7, 8]. In the
absence of data to support the benefit versus harm of
routine screening, average-risk women in their 40s were
advised to engage in an individual shared decision mak-
ing process with their provider to determine if screening
was right for them [7, 8].
Shared decision making is a process where the patient
and clinician share information with each other, assess
evidence and values, and mutually agree upon a course
of action. The goal is to create the activated patient - a
patient who is well-informed about the benefits and
harms of a particular issue and feels comfortable that
her choice reflects the appropriate combination of clin-
ical input, evidence and personal values [9, 10]. Shared
decision making is ideal when the tradeoff between ben-
efits and harms is either unclear or unknown.
A recently updated Cochrane review on decision mak-
ing concluded that decision aids are better than usual
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care interventions in providing patients with knowledge
and reducing conflict about making a decision [11]. Pa-
tients have a more realistic expectation of benefits and
harms as well as the values surrounding them. They also
activate undecided or passive patients to make a deci-
sion. For example, exposure to these tools resulted in
patients choosing more conservative surgery options and
reduced prostate specific antigen (PSA) screening [11].
There are a wide variety of decision making resources
that can be used to facilitate a shared decision making
process. At one end of the spectrum, a decision aid can
be a simple, patient-focused brochure that explains the
benefits and harms of a specific procedure. On the other
end of the spectrum, it can be a web-based, interactive
tool that engages the patient to respond to specific ques-
tions while providing targeted information and feedback
based on probabilistic models [12–14]. In this project
the goal was development and evaluation of a web-based
decision aid that helped average-risk women in their 40s
understand, rank and sort their values regarding screening
mammography. At the end of this process the woman was
presented with a summary document intended to facilitate
a shared decision making conversation between her and
her provider.
This manuscript explores the decision aid develop-
ment process, refinement through iterative feedback,
and performance in a pilot cohort. The aims of this pilot
study were 1) to explore the impact of a web-based pa-
tient decision aid on a woman’s decisional conflict about
the screening mammography decision, and 2) to explore
their values related to screening mammography through
an explicit values-clarification exercise included in a pa-
tient decision aid.
Significance
Breast cancer is the most common cancer diagnosed in
women and the second leading cause of cancer death
[15]. There is no effective way to prevent breast cancer
which is why the appropriate application of screening
mammography is critical. The benefits of having a screen-
ing mammogram must outweigh the harms of not having
the test or of having a test result that is falsely positive. This
is known as net benefit. Conflicting data about whether
average-risk women in their 40s experience a net benefit
from routine screening mammograms led the USPSTF to
recommend that they engage in an individualized shared
decision making process. The goal was to empower these
women to make a screening decision that is right for them.
Methods
Decision aid description
The decision aid was organized into six sections and the
content was guided by International Patient Decision
Aid Standards (IPDAS) collaboration criteria [16]: (1)
welcome, (2) breast cancer risk factors, (3) mammog-
raphy information, (4) values clarification, (5) summary
and (6) final questions. The welcome section defined
screening, contrasted diagnostic and screening mammog-
raphy, and explored the population risk of breast cancer
using pictographs (Fig. 1). The risk factors section explored
most modifiable and non-modifiable risk factors for breast
cancer development. The mammography section described
the screening process, safety of it, timing between mam-
mography screenings, and the possible incorrect outcomes
of a screening mammogram.
The values clarification section was comprised of two
exercises. First, the woman was asked to slide an indica-
tor box on a series of scale bars (see Additional file 1) to
reflect the importance of ten factors on her decision to
having a screening mammogram: avoiding false posi-
tives, avoiding false negatives, peace of mind, catching
cancer early, overdiagnosis, stress & fear, time & access,
embarrassment & pain, radiation exposure and cost. The
factors chosen for assessment reflected major concerns
raised in the biomedical literature and vetted with subject
matter experts, described in the Decision Aid Development
section. The women could not add additional factors.
Fig. 1 Current breast cancer risk. Infographic depicting current breast cancer risk statistic for average-risk women in their 40s
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The goal was for the woman to interpret the informa-
tion presented in light of her personal values and cir-
cumstances. For example, one questions asked was
“Which is more important to you, having a positive test
when cancer is present or avoiding a positive test when
cancer is not present?” The far left hand side of the scale
bar was labeled “Having a Positive Test When Cancer is
Present” while the far right hand side of the scale was la-
beled “Avoiding a Positive Test When There is No Cancer”.
The woman then moved the indicator box on the scale bar
to the point that reflected her balance point in considering
the risks versus benefits of these two possible outcomes.
The second part of the values clarification exercise
entailed ranking these ten factors into one of three cat-
egories: (1) most important, (2) moderate importance, or
(3) least important (Fig. 2). In the process of performing
this ranking exercise, a woman came to understand her
expectations and concerns surrounding screening mam-
mography. This information was then captured and in-
cluded as part of a summary that the woman received
when she completed the aid. The woman was encour-
aged to review this information and discuss it with her
primary care provider as part of her individualized
shared decision making process.
Decision aid development
Several resources were leveraged for developing and
refining the screening mammography decision aid
throughout 2010 and into the first half of 2011. An
extensive review of the biomedical literature was step
one. This was used to determine the initial scope
and content of the aid [7, 8, 17–19]. Several rounds
of internal testing were conducted with informatics
graduate students to assess the technical aspects and us-
ability of the decision aid. Healthcare professional and
graduate students also provided feedback on content,
comprehensibility, length and adherence to privacy and
security standards.
Before testing with patients, five subject matter experts
from the USPSTF, National Cancer Institute (NCI), the
Agency for Healthcare Research (AHRQ), the American
Cancer Society (ACS) and the American College of Ob-
stetricians and Gynecologists (ACOG) and five clinical
experts in women’s health were interviewed for face val-
idity and on their impression of and experience using
the decision aid. The semi-structured interview ques-
tions probed issues such as whether the message for an
ineligible (above-average-risk) woman was sensitive and
encouraged her to follow-up with her own healthcare
provider. The experts also identified ways to make the
content and output useful for discussions with the
woman’s healthcare provider.
This solicited feedback from subject matter and clin-
ical experts during development was an unusual but
valuable step in shaping this decision aid. It was key in
honing tool content as well as raising and exploring un-
foreseen issues. Furthermore, it allowed for a better un-
derstanding of how to handle the epidemiologic divide
Fig. 2 Values clarification. Ranking factors to consider when making a decision about screening mammography, by importance
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that prevents the experts from agreeing on a single
breast cancer screening recommendation.
Recommendations included replacing terms like “false
negatives” with plain language such as, “results that say
you don’t have cancer when you actually do.” Many ex-
perts also recommended enhancing decision tree dia-
grams with flash animations or explanatory text, and
providing the user with hyperlinks to definitions of more
complex words or potentially confusing concepts. Revi-
sions were made to the decision aid to incorporate these
suggestions.
The decision aid was password protected and access-
ible through web browsers including Mozilla Firefox and
Microsoft Internet Explorer.
Ethics and consent
This study was approved by the OHSU Research Integ-
rity Office (eIRB #7118). All enrolled women completed
informed consent. For confidentiality reasons, only the
group results are presented and no additional supple-
mentary data are available to researchers.
Protocol and participants
In August 2011 social media (i.e., Facebook) and inter-
personal networking (i.e., friend-to-friend) was leveraged
to recruit women for this pilot project. Sixty-four women
indicated their desire to participate in the pilot by sending
an email to the research team. In response, each woman
was provided with a username, password and detailed in-
structions for accessing the aid. Subject eligibility was deter-
mined through a computerized risk assessment algorithm
(described below). Six women were ineligible due to age or
were above-average breast cancer risk; five enrolled but did
not log into the tool; and two logged into the tool but did
not complete the entire process. The remaining 51 age-risk
appropriate women test piloted the decision aid. They
received a $15.00 Starbuck’s Card eGift by email as a
token of appreciation.
Risk assessment
Women accessed the risk assessment on a personal
computer through the Internet with a username and
password. Once in the website, each woman engaged in
a series of risk stratification questions aimed at identify-
ing and restricting women with an increased risk of de-
veloping breast from engaging with the decision aid [20].
This algorithm included personal and family history of
breast or ovarian cancer, genetic markers for breast can-
cer, current breast symptoms, or a prior history of radi-
ation. Women with an above-average risk of developing
breast cancer were directed to appropriate screening and
follow-up in accordance with best practices. Average-
risk women then moved on to use the decision aid.
Measures and analyses
Women were asked baseline questions regarding their
intention to obtain a screening mammogram in the next 1-
2 years. They then completed a series of ten questions de-
signed to assess their baseline decisional conflict around
making a screening mammography choice (Table 1). This
Decisional Conflict Scale (DCS) measured the amount of
certainty, clarity of values, level of support and how in-
formed a woman felt when making a decision about screen-
ing mammography. The DCS used here has been well-
validated in the medical literature [21–23]. Next, each
woman answered questions on basic demographic informa-
tion including race, education level, income, and health in-
surance. In addition, she provided information on history
of mammograms, prior false-positive screens and intention
to have (or continue to have) screening mammograms.
To further measure the specific impact of the decision
aid on each woman’s decision making process, scores
from the four subscales and summary scale of the low-
literacy version of the DCS were calculated [24]. For
each of ten statements, e.g., “Do you know what your
options are for breast cancer screening?”, the patient re-
sponds with “Yes” (zero points), “No” (four points), or
“Unsure” (two points). The mean score of the questions
was determined for each subscale (feeling uninformed;
feeling uncertain, having unclear values; feeling unsup-
ported) and multiplied by 25. The mean score of all
questions was also determined and multiplied by 25 to
create a summary score. Summary scores of zero suggest
an overall good decision process (no decisional conflict);
scores of 100 suggest a poor decision process (extremely
high decisional conflict). Improvement was measured by
reduction in scores. This instrument was completed by
all participants prior to engaging with the content of the
decision aid and after completing their interaction with
Table 1 Modified low-literacy decision conflict scale
Participants answered Yes, Unsure, or No to each of the following questions:
1. Do you know what mammography screening options are
available to you?
2. Do you know the benefits of each option?
3. Are you clear about which benefits matter most to you?
4. Do you know the risks and side effects of each option?
5. Are you clear about which risks and side effects matter most to you?
6. Do you have enough support from others to make a choice?
7. Are you choosing without pressure from others?
8. Do you have enough advice to make a choice?
9. Are you clear about the best choice for you?
10. Do you feel sure about what to choose?
The Decisional Conflict Scale [24], low literacy format, was adapted to measure
the overall amount of conflict experienced when considering a decision about
screening mammography. Scale subscores provided additional information on
knowledge, values clarity, support and certainty
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it. This facilitated discrimination between patients who
make decisions and patients who delay making decisions
because of uncertainty [24, 25].
Sample size justification
Decisional conflict was the primary outcome assessed
in this pilot study, and as such we looked to prior
experimental studies to guide our plans regarding
sample size. A similar pre-post study design, which evalu-
ated a breast cancer prevention decision aid combined with
counseling, enrolled 17 higher-risk women [25]. That study
reported a reduction in overall decisional conflict, but the
reductions were not statistically significant (p > 0.05) in any
of the subscales, possibly due to the study’s limited sample
size. The decision aid in our present study was designed
for average-risk women, and it was not clear to us whether
our study’s participants would have similar baseline levels
of decisional conflict to those observed by Stacey [26]
among higher-risk women. As such, we took a conservative
approach and planned to recruit 50 women to participate
in this pilot study.
Statistical analyses were carried out using IBM SPSS
Statistics 19 (IBM Corporation, Somers, NY, USA) be-
tween September 30 and November 1, 2011. Descriptive
statistics were calculated for all variables of interest.
Continuous measures were summarized using means
and standard deviations. Categorical measures were
summarized using counts and percentages. The two
main outcomes of interest, intention to obtain a screen-
ing mammogram and decisional conflict, were mea-
sured in a pre-post fashion. Because these variables
were not normally distributed, a Wilcoxon signed-rank
test was used to assess significance. A significance level
of 0.05 was used unless multiple comparisons were in-
dicated. In the latter case a significance level of 0.01 or
appropriate correction (i.e., Bonferroni) was used.
Results
A convenience sample of 51 women aged 38 - 48 with no
known risk factors for developing breast cancer partici-
pated in this pilot study between August 22 and September
24, 2011. This cohort was predominantly white (84 %),
well-educated (78 % with at least a college degree), insured
(98 % had health insurance) and financially comfortable
(45 % with an annual household income of at least
$100,000) (Table 2). Thirty-eight women (74 %) re-
ported having at least one prior mammogram with 19
of them (50 %) experiencing a false positive test re-
sult at some point in time (Table 2).
When asked whether they planned to have a mammo-
gram in the next 1-2 years, 42 women (82 %) said yes, 4
(8 %) were undecided and 5 (10 %) said no. At baseline,
13 women (25 %) experienced no decisional conflict
(scored 0 for overall decisional conflict) and 6 (12 %)
had some decisional conflict with scores between 1 and
25. Scores below 25 are associated with making deci-
sions (O’Connor, decisional conflict manual, 2010).
Ten women (21 %) had overall decisional conflict
scores between 26 and 50; 14 (27 %) had had scores be-
tween 51 and 75; and 8 (16 %) had scores above 75.
This suggests that the majority of women had scores
over the threshold for making decisions and were likely
to delay the decision [24].
Also at baseline, 45 women (88 %) indicated a belief
that women in their 40s benefit from screening mam-
mography and that the choice to have a screening mam-
mogram should be something that they themselves
decide (63 %) or a decision that is made together with
their healthcare provider (37 %). No member of this co-
hort felt that a healthcare provider should make this






More than 1 1 (2)
Education Level
HS Diploma 1 (2)
Some College 10 (20)
College Degree 21 (41)
Some Graduate 7 (14)
Graduate Degree 12 (23)
Income
10 K - <25 K 1 (2)
25 K - < 50 K 6 (12)
50 K - < 100 K 19 (37)
100 K or more 23 (45)







Prior False Positive Screen
Yes 19 (37)
No 19 (37)
Not Applicable 13 (26)
This cohort was predominantly white (84 %), well-educated (78 % with at least
a college degree), insured (98 % had health insurance) and financially comfortable
(45 % with an annual household income of at least $100,000). Thirty-eight women
(74 %) reported having at least one prior mammogram with 19 of them
(50 %) experiencing a false positive test result at some point in time
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decision for them or expressed uncertainty about who
should make this choice.
A Wilcoxon signed-rank test was used to compare a
woman’s plans for screening mammography before and
after using the decision aid. After using the decision aid,
women reported a significant reduction in overall deci-
sional conflict (Z = -5.3, p < 0.001) as well as statistically sig-
nificant reductions in each of the decisional conflict
subscales: feeling uncertain (Z = -4.7, p < 0.001), feeling un-
informed (Z = -5.2, p < 0.001), feeling unclear about values
(Z = -5.0, p < 0.001), and feeling unsupported (Z = -4.0,
p < 0.001) (Table 3). However, these women reported
no change in screening intention (Z = -1.5, p = 0.132).
During the ranking exercise, women were asked to clas-
sify ten factors - time & access, peace of mind, embarrass-
ment & pain, false positive test results, false negative test
results, radiation exposure, cancer detection, overdiagnosis,
stress & fear, and cost - into one of three buckets: most im-
portant, moderately important, or least important. Catch-
ing cancer earlier through screening was ranked most
important by 44 (86 %) women. This was followed closely
by peace of mind (84 %). Other factors ranked with high
and moderate importance included avoiding false negative
tests, avoiding false positive tests, overdiagnosis and radi-
ation exposure (Fig. 3).
Discussion
This pilot study of a breast cancer screening decision aid
with a convenience sample of 51 age- and risk-appropriate
women offers two main contributions. First, it demon-
strates that decisional conflict about screening mammog-
raphy may be significantly impacted by the use of a
decision aid. Women in this pilot study felt more certain,
better informed and better supported, and they demon-
strated increased clarity of values in their decision making
process. This finding is tempered by lack of a control con-
dition and the fact that these women had no change in
the intention to obtain a routine screening mammogram.
This latter finding, while interesting, is not all together un-
expected. Most (88 %) of the women in this sample held
the baseline belief that women in their 40s benefit from
screening mammography; 74 % had a prior mammogram;
and 82 % planned to have a mammogram within the next
year. This seems to reflect long-standing cultural and peer
norms which one wouldn’t expect to shift readily or easily.
This absence of a change in intention to obtain a routine
screening mammogram also raises the question of the clin-
ical impact and value of this decision aid. Here we must be
clear that the shared decision making process itself, initi-
ated through this decision aid and independent of the final
choice(s) made, has significant clinical value that should
not be marginalized. This includes the benefits of patient
engagement and satisfaction; standardization of best prac-
tice messaging; more realistic expectations of risks and
harms; as well as a more efficient use of the clinician’s time.
The second contribution is the use of a values clarifi-
cation technique involving rating the importance of se-
lected factors that might impact the screening decision
and then ranking those factors. More than 80 % of the
women in this study ranked peace of mind and detecting
a cancer early as the “most important” factors to con-
sider when making a decision about screening mammog-
raphy. This was followed by “most important” concerns
around avoiding false negatives (41 %), avoiding false posi-
tive (31 %) and overdiagnosis (26 %). This seemed indica-
tive of an understanding of these more nuanced terms as
well as the risk-benefit associated with screening mam-
mography. Less than 5 % of the women ranked cost as a
“most important” factor. This may reflect the high income
level of the group or the expanding knowledge that free
screening mammography is readily available.
This pilot study contains limitations that can be lifted
with future research. First, the decision aid was tested with
a convenience sample of women who were predominantly
white, well-educated and highly resourced. These women
were not representative of the general population, and the
findings from this study cannot be generalized. Second, the
aid was available only in format requiring internet access.
Users of iPads and smart phones were also excluded,
though it should be noted that use of such devices was
less common at the time the study was conducted than
today. Finally, the aid may have been too long. During
usability testing it took approximately 35 min to get
through the entire decision aid.
Table 3 Decisional conflict scale pre- and post-scores
Category Pre-score Std. Dev Post-score Std. Dev Delta Statistica
Overall 40.6 31.0 6.4 13.1 −34.2 Z = -5.3, p < 0.001
Subscores
Uncertain 50.5 41.4 12.8 27.6 −37.7 Z = -4.7, p < 0.001
Uninformed 47.4 38.2 3.9 14.8 −43.5 Z = -5.2, p < 0.001
Unclear values 51.0 42.7 5.9 21.0 −45.1 Z = -5.0, p < 0.001
Unsupported 20.3 22.2 4.9 10.7 −15.4 Z = -4.0, p < 0.001
aWilcoxan Signed-Rank Test
Significant reduction was seen in overall decisional conflict scores, and in each of the decisional conflict subscores
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The limitations identified in this pilot are now being ad-
dressed through a follow-on study funded by the McKesson
Foundation’s Mobilizing For Health Grant Program. The
decision aid has been redesigned as an app on a mobile de-
vice. The target audience for the app is low-income,
average-risk women in their forties, who are not regu-
larly screening and who seek care in rural clinics. As
with this pilot, the women enrolled in the follow-on
study also undergo a breast cancer risk assessment to con-
firm eligibility. Above-average-risk women are then given
resources to help them obtain timely and appropriate
follow-up screening, and average-risk women are invited to
engage with the decision aid and make an informed choice
based on their own preferences or priorities.
Conclusion
This breast cancer screening decision aid brought value to
patient care not by impacting what a woman chose, but by
impacting why or how she chose it. There are several ways
to decrease conflict, including becoming informed about
choices for screening; feeling supported in the screening
decision; knowing personal priorities around the decision;
and feeling certain about the decision. The decision aid de-
scribed in this pilot study addressed all of these aspects of
the decision making process.
Additional file
Additional file 1: Screen shots depicting the Values Clarification
section of the Mammography Screening Decision Aid. (PDF 332 kb)
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